Sevoflurane reverses cisplatin resistance in neuroblastoma cells through the linc00473/miR-490-5p/AKT1 axis

References

1. 1.↵
   1. Cogo SC,
   2. da Costa do Nascimento TGF,
   3. de Almeida Brehm Pinhatti F,
   4. de França Junior N,
   5. Rodrigues Bs,
   6. Cavalli LR, et al.

   An overview of neuroblastoma cell lineage phenotypes and in vitro models. Exp Biol Med (Maywood). 2020; 245: 1637–1647.

   OpenUrl
2. 2.↵
   1. Duan M,
   2. Ulibarri J,
   3. Liu KJ,
   4. Mao P.

   Role of nucleotide excision repair in cisplatin resistance. Int J Mol Sci 2020; 21: 9248.

   OpenUrl
3. 3.↵
   1. Yang C,
   2. Tan J,
   3. Zhu J,
   4. Wang S,
   5. Wei G.

   YAP promotes tumorigenesis and cisplatin resistance in neuroblastoma. Oncotarget 2017; 8: 37154–37163.

   OpenUrl
4. 4.↵
   1. Sun Y,
   2. Qiao Y,
   3. Liu Y,
   4. Zhou J,
   5. Wang X,
   6. Zheng H, et al.

   ent-Kaurane diterpenoids induce apoptosis and ferroptosis through targeting redox resetting to overcome cisplatin resistance. Redox Biol 2021; 43: 101977.

   OpenUrl
5. 5.↵
   1. Quan Y,
   2. Li S,
   3. Wang Y,
   4. Liu G,
   5. Lv Z,
   6. Wang Z.

   Propofol and Sevoflurane Alleviate Malignant Biological Behavior and Cisplatin Resistance of Xuanwei Lung Adenocarcinoma by Modulating the Wnt/β-catenin Pathway and PI3K/AKT Pathway. Anticancer Agents Med Chem 2022; 22: 2098–2108.

   OpenUrl
6. 6.↵
   1. Zhang L,
   2. Wang Y,
   3. Li X,
   4. Xia X,
   5. Li N,
   6. He R, et al.

   ZBTB7A Enhances Osteosarcoma Chemoresistance by Transcriptionally Repressing lncRNALINC00473-IL24 Activity. Neoplasia 2017;19:908–918.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Wang L,
   2. Zhang X,
   3. Sheng L,
   4. Qiu C,
   5. Luo R.

   LINC00473 promotes the Taxol resistance via miR-15a in colorectal cancer. Biosci Rep 2018; 38: BSR20180790.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Wei X,
   2. Xu S,
   3. Chen L.

   LncRNA Neat1/miR-298-5p/Srpk1 Contributes to Sevoflurane-Induced Neurotoxicity. Neurochem Res 2021; 46: 3356–3364.

   OpenUrl
9. 9.↵
   1. Xu W,
   2. Zhao Y,
   3. Ai Y.

   Overexpression of lncRNA Gm43050 alleviates apoptosis and inflammation response induced by sevoflurane treatment by regulating miR-640/ZFP91. Am J Transl Res 2020; 12: 4337–4346.

   OpenUrl
10. 10.↵
    1. Chen H,
    2. Fang T,
    3. Liu F,
    4. Pang L,
    5. Wen Y,
    6. Chen S, et al.

    Career adaptability research: A literature review with scientific knowledge mapping in Web of Science. Int J Environ Res Public Health 2020; 17: 5986.

    OpenUrl
11. 11.↵
    1. Li C,
    2. Yang C,
    3. Wei G.

    Vandetanib inhibits cisplatin resistant neuroblastoma tumor growth and invasion. Oncol Rep 2018; 39: 1757–1764.

    OpenUrlCrossRef
12. 12.↵
    1. Li H,
    2. Zhao X,
    3. Wen X,
    4. Zeng A,
    5. Mao G,
    6. Lin R, et al.

    Inhibition of miR-490-5p Promotes Human Adipose-Derived Stem Cells Chondrogenesis and Protects Chondrocytes via the PITPNM1/PI3K/AKT Axis. Front Cell Dev Biol 2020; 8: 573221.

    OpenUrl
13. 13.↵
    1. Tang C,
    2. Luo H,
    3. Luo D,
    4. Yang H,
    5. Zhou X.

    Src homology phosphotyrosyl phosphatase 2 mediates cisplatin-related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells. Oncol Rep 2018; 39: 611–618.

    OpenUrl
14. 14.↵
    1. Gunda V,
    2. Pathania AS,
    3. Chava S,
    4. Prathipati P,
    5. Chaturvedi NK,
    6. Coulter DW, et al.

    Amino acids regulate cisplatin insensitivity in neuroblastoma. Cancers (Basel) 2020; 12: 2576.

    OpenUrl
15. 15.↵
    1. Rodrigo MAM,
    2. Michalkova H,
    3. Strmiska V,
    4. Casar B,
    5. Crespo P,
    6. de Los Rios V, et al.

    Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma. Sci Rep 2021; 11: 5496.

    OpenUrl
16. 16.↵
    1. Xu Z,
    2. Sun Y,
    3. Wang D,
    4. Sun H,
    5. Liu X.

    SNHG16 promotes tumorigenesis and cisplatin resistance by regulating miR-338-3p/PLK4 pathway in neuroblastoma cells. Cancer Cell Int 2020; 20: 236.

    OpenUrl
17. 17.↵
    1. Zhang S,
    2. Ma H,
    3. Zhang D,
    4. Xie S,
    5. Wang W,
    6. Li Q, et al.

    LncRNA KCNQ1OT1 regulates proliferation and cisplatin resistance in tongue cancer via miR-211-5p mediated Ezrin/Fak/Src signaling. Cell Death Dis 2018; 9: 742.

    OpenUrl
18. 18.↵
    1. Yang X,
    2. Li F,
    3. Ma J,
    4. Liu Y,
    5. Wang X,
    6. Wang R, et al.

    Study on the Relationship between the miRNA-centered ceRNA regulatory network and fatigue. J Mol Neurosci 2021; 71: 1967–1974.

    OpenUrl
19. 19.↵
    1. Fang ZQ,
    2. Li MC,
    3. Zhang YQ,
    4. Liu XG.

    MiR-490-5p inhibits the metastasis of hepatocellular carcinoma by down-regulating E2F2 and ECT2. J Cell Biochem 2018; 119: 8317–8324.

    OpenUrl
20. 20.↵
    1. Abdeyrim A,
    2. Cheng X,
    3. Lian M,
    4. Tan Y.

    miR 490 5p regulates the proliferation, migration, invasion and epithelial mesenchymal transition of pharyngolaryngeal cancer cells by targeting mitogen activated protein kinase kinasekinase 9. Int J Mol Med 2019; 44: 240–252.

    OpenUrl
21. 21.↵
    1. Guerau-de-Arellano M,
    2. Piedra-Quintero ZL,
    3. Tsichlis PN.

    Akt isoforms in the immune system. Front Immunol 2022; 13: 990874.

    OpenUrl
22. 22.↵
    1. Yu X,
    2. Wang R,
    3. Zhang Y,
    4. Zhou L,
    5. Wang W,
    6. Liu H, et al.

    Skp2-mediated ubiquitination and mitochondrial localization of Akt drive tumor growth and chemoresistance to cisplatin. Oncogene 2019; 38: 7457–7472.

    OpenUrl
23. 23.↵
    1. Zhang S,
    2. Wang Y.

    Deoxyshikonin inhibits cisplatin resistance of non-small-cell lung cancer cells by repressing Akt-mediated ABCB1 expression and function. J Biochem Mol Toxicol 2020; 34: e22560.

    OpenUrl